Cannabinoid agonists and antagonists are provided for use in the treatment
of disorders such as acute and chronic pain, inflammation, loss of
appetite, convulsions, multiple sclerosis, nausea and vomiting. The
cannabinoid agonists and antagonists contain a sulfonamide moiety
incorporated into the cannabinoid side chain, and the side chain itself
may be saturated or unsaturated.
